Literature DB >> 26223802

ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.

Sonu Singh1, Akanksha Mishra1, Shubha Shukla2.   

Abstract

Oxidative stress and neuroinflammation are known causative factors in progressive degeneration of dopaminergic (DAergic) neurons in Parkinson's disease (PD). Neural stem cells (NSCs) contribute in maintaining brain plasticity; therefore, survival of NSCs and neuroblasts during neurodegenerative process becomes important in replenishing the pool of mature neuronal population. Acetyl-L-carnitine (ALCAR), present in almost all body cells, increases endogenous antioxidants and regulates bioenergetics. Currently, no information is available about the putative mechanism and neuroprotective effects of ALCAR in 6-hydroxydopamine (6-OHDA)-induced rat model of PD-like phenotypes. Herein, we investigated the effect of ALCAR on death/survival of DAergic neurons, neuroblasts and NSCs and associates mechanism of neuroprotection in 6-OHDA-induced rat model of PD-like phenotypes. ALCAR (100 mg/kg/day, intraperitoneal (i.p.)) treatment started 3 days prior to 6-OHDA lesioning and continued for another 14 day post-lesioning. We found that ALCAR pretreatment in 6-OHDA-lesioned rats increased expression of neurogenic and the Wnt pathway genes in the striatum and substantia nigra pars compacta (SNpc) region. It suppressed the glial cell activation, improved antioxidant status, increased NSC/neuroblast population and rescued the DAergic neurons in nigrostriatal pathway. ALCAR pretreatment in 6-OHDA-lesioned rats decreased GSK-3β activation and increased nuclear translocation of β-catenin. Functional deficits were restored following ALCAR pretreatment in 6-OHDA-lesioned rats as demonstrated by improved motor coordination and rotational behaviour, confirming protection of DAergic innervations in lesioned striatum. These results indicate that ALCAR exerts neuroprotective effects through the activation of Wnt/β-catenin pathway, suggesting its therapeutic use to treat neurodegenerative diseases by enhancing regenerative capacity.

Entities:  

Keywords:  Acetyl-L-carnitine (ALCAR); Neural stem cells; Neuroblasts; Neuroprotection; Oxidative stress; Wnt/β-catenin pathway

Mesh:

Substances:

Year:  2015        PMID: 26223802     DOI: 10.1007/s12035-015-9361-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  57 in total

1.  Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation.

Authors:  Young C Chung; Sang R Kim; Ju-Young Park; Eun S Chung; Keun W Park; So Y Won; Eugene Bok; Minyoung Jin; Eun S Park; Sung-Hwa Yoon; Hyuk W Ko; Yoon-Seong Kim; Byung K Jin
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

2.  A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.

Authors:  M I Colado; E O'Shea; R Granados; A Misra; T K Murray; A R Green
Journal:  Br J Pharmacol       Date:  1997-06       Impact factor: 8.739

3.  Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates.

Authors:  E F Espejo; R J Montoro; J A Armengol; J López-Barneo
Journal:  Neuron       Date:  1998-02       Impact factor: 17.173

4.  Acetyl-L-carnitine-mediated neuroprotection during hypoxia is attributed to ERK1/2-Nrf2-regulated mitochondrial biosynthesis.

Authors:  Kalpana Barhwal Hota; Sunil Kumar Hota; Om Prakash Chaurasia; Shashi Bala Singh
Journal:  Hippocampus       Date:  2011-05-03       Impact factor: 3.899

5.  Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.

Authors:  Stuart A Montgomery; L J Thal; R Amrein
Journal:  Int Clin Psychopharmacol       Date:  2003-03       Impact factor: 1.659

6.  Effects of long-term acetyl-L-carnitine administration in rats: I. increased dopamine output in mesocorticolimbic areas and protection toward acute stress exposure.

Authors:  Pierluigi Tolu; Flavio Masi; Benedetta Leggio; Simona Scheggi; Alessandro Tagliamonte; M Graziella De Montis; Carla Gambarana
Journal:  Neuropsychopharmacology       Date:  2002-09       Impact factor: 7.853

7.  Neurod1 is essential for the survival and maturation of adult-born neurons.

Authors:  Zhengliang Gao; Kerstin Ure; Jessica L Ables; Diane C Lagace; Klaus-Armin Nave; Sandra Goebbels; Amelia J Eisch; Jenny Hsieh
Journal:  Nat Neurosci       Date:  2009-08-23       Impact factor: 24.884

Review 8.  Involvement of basal ganglia transmitter systems in movement initiation.

Authors:  W Hauber
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

9.  Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.

Authors:  Lilia Marinova-Mutafchieva; Mona Sadeghian; Lauren Broom; John B Davis; Andrew D Medhurst; David T Dexter
Journal:  J Neurochem       Date:  2009-06-22       Impact factor: 5.372

10.  Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF.

Authors:  Fan Yang; Yunhui Liu; Jie Tu; Jun Wan; Jie Zhang; Bifeng Wu; Shanping Chen; Jiawei Zhou; Yangling Mu; Liping Wang
Journal:  Nat Commun       Date:  2014-12-17       Impact factor: 14.919

View more
  14 in total

1.  Acetyl-L-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats.

Authors:  Sonu Singh; Akanksha Mishra; Neha Srivastava; Rakesh Shukla; Shubha Shukla
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

2.  Glycogen Synthase Kinase-3β Regulates Equilibrium Between Neurogenesis and Gliogenesis in Rat Model of Parkinson's Disease: a Crosstalk with Wnt and Notch Signaling.

Authors:  Sonu Singh; Akanksha Mishra; Sachi Bharti; Virendra Tiwari; Jitendra Singh; Shubha Shukla
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

Review 3.  Parkinson's disease, aging and adult neurogenesis: Wnt/β-catenin signalling as the key to unlock the mystery of endogenous brain repair.

Authors:  Bianca Marchetti; Cataldo Tirolo; Francesca L'Episcopo; Salvatore Caniglia; Nunzio Testa; Jayden A Smith; Stefano Pluchino; Maria F Serapide
Journal:  Aging Cell       Date:  2020-02-12       Impact factor: 9.304

4.  Spinacia oleracea extract attenuates disease progression and sub-chondral bone changes in monosodium iodoacetate-induced osteoarthritis in rats.

Authors:  Dharmendra Choudhary; Priyanka Kothari; Ashish Kumar Tripathi; Sonu Singh; Sulekha Adhikary; Naseer Ahmad; Sudhir Kumar; Kapil Dev; Vijay Kumar Mishra; Shubha Shukla; Rakesh Maurya; Prabhat R Mishra; Ritu Trivedi
Journal:  BMC Complement Altern Med       Date:  2018-02-20       Impact factor: 3.659

5.  Osteocalcin Ameliorates Motor Dysfunction in a 6-Hydroxydopamine-Induced Parkinson's Disease Rat Model Through AKT/GSK3β Signaling.

Authors:  Xing-Zhi Guo; Chang Shan; Yan-Fang Hou; Geng Zhu; Bei Tao; Li-Hao Sun; Hong-Yan Zhao; Guang Ning; Sheng-Tian Li; Jian-Min Liu
Journal:  Front Mol Neurosci       Date:  2018-09-27       Impact factor: 5.639

6.  β-Catenin signaling positively regulates glutamate uptake and metabolism in astrocytes.

Authors:  Victoria Lutgen; Srinivas D Narasipura; Amit Sharma; Stephanie Min; Lena Al-Harthi
Journal:  J Neuroinflammation       Date:  2016-09-10       Impact factor: 8.322

Review 7.  Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation.

Authors:  Bruno Di Marco Vieira; Rowan A Radford; Roger S Chung; Gilles J Guillemin; Dean L Pountney
Journal:  Front Cell Neurosci       Date:  2015-11-12       Impact factor: 5.505

8.  Clematichinenoside Serves as a Neuroprotective Agent Against Ischemic Stroke: The Synergistic Action of ERK1/2 and cPKC Pathways.

Authors:  Chao Liu; Qianming Du; Xu Zhang; Zhichao Tang; Hui Ji; Yunman Li
Journal:  Front Cell Neurosci       Date:  2016-01-12       Impact factor: 5.505

9.  Downregulation of the Repressor Element 1-Silencing Transcription Factor (REST) Is Associated with Akt-mTOR and Wnt-β-Catenin Signaling in Prion Diseases Models.

Authors:  Zhiqi Song; Syed Z A Shah; Wei Yang; Haodi Dong; Lifeng Yang; Xiangmei Zhou; Deming Zhao
Journal:  Front Mol Neurosci       Date:  2017-05-03       Impact factor: 5.639

10.  Physiological and Functional Basis of Dopamine Receptors and Their Role in Neurogenesis: Possible Implication for Parkinson's disease.

Authors:  Akanksha Mishra; Sonu Singh; Shubha Shukla
Journal:  J Exp Neurosci       Date:  2018-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.